Community-Based Parenteral Anti-Infective Therapy (CoPAT)
- 1 January 1998
- journal article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 35 (1) , 65-77
- https://doi.org/10.2165/00003088-199835010-00005
Abstract
Community-based parenteral anti-infective therapy (CoPAT) has, over the past 20 years, increased rapidly in many parts of the world including North America, Europe, South America and Australia. CoPAT is a multidisciplinary activity demanding close cooperation between nurses, pharmacists and physicians, as well as with the patient. The selection of an anti-infective drug for use outside the hospital setting must take into account not only the therapeutic effectiveness, cost effectiveness and safety of the drug, but also pharmacological factors such as the dosage schedule and the stability of the drug. Dosage schedules vary with pharmacokinetic factors (e.g. the use of drugs with long half-lives are favoured by CoPAT programmes) and pharmacodynamic features (e.g. once daily gentamicin therapy is attractive and practical because of concentration-dependent bactericidal killing and prolonged post-antibiotic effect). With selected drugs, the renal and, to a lesser degree, liver function of the patient will influence the dosage schedule. The mode of intravenous (i.v.) drugs administration will vary with volume considerations (limiting the use of syringe-infusion therapy for some drugs), stability issues (prevents drugs that are stable at room temperature for less than 24 hours from being used in multidose computerised delivery systems), as well as patient factors (ability to self administer an i.v. drug). Monitoring serum anti-microbial concentrations is undertaken to assure effectiveness and avoid toxicity, and is indicated for drugs with a narrow therapeutic window, such as the aminoglycosides. With the advent of the single daily dose administration of aminoglycosides, checking serum concentrations at the mid-point, i.e. 6 to 14 hours following administration of the first dose, is one approach. Because the toxic effects of vancomycin have been overstated, serum concentrations should only be obtained for defined indications primarily to assure therapeutic effectiveness.Keywords
This publication has 52 references indexed in Scilit:
- Model-Based, Goal-Oriented, Individualised Drug TherapyClinical Pharmacokinetics, 1998
- Practice Guidelines for Community‐Based Parenteral Anti‐Infective TherapyClinical Infectious Diseases, 1997
- Predicting the clinical efficacy of antibiotics: toward definitive criteriaThe Pediatric Infectious Disease Journal, 1997
- Safe intravenous antibiotic therapy at home: experience of a UK based programmeJournal of Antimicrobial Chemotherapy, 1996
- Antibiotic selection factors and description of a hospital-based outpatient antibiotic therapy program in the USAEuropean Journal of Clinical Microbiology & Infectious Diseases, 1995
- The Importance of Pharmacokinetic/Pharmacodynamic Surrogate Markers to OutcomeClinical Pharmacokinetics, 1995
- An Application of Microdialysis to Drug Tissue Distribution Study: In Vivo Evidence for Free-Ligand Hypothesis and Tissue Binding of .BETA.-Lactam Antibiotics in Interstitial Fluids.Journal of Pharmacobio-Dynamics, 1992
- Adverse reactions following intravenous penicillin-G relate to degradation of the drug in vitroJournal of Molecular Medicine, 1984
- EFFECT OF STORAGE OF PENICILLIN-G SOLUTIONS ON SENSITISATION TO PENICILLIN-G AFTER INTRAVENOUS ADMINISTRATIONThe Lancet, 1982
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976